1. Home
  2. PSMT vs LQDA Comparison

PSMT vs LQDA Comparison

Compare PSMT & LQDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo PriceSmart Inc.

PSMT

PriceSmart Inc.

SELL

Current Price

$169.53

Market Cap

5.2B

ML Signal

SELL

LQDA

Liquidia Corporation

SELL

Current Price

$33.86

Market Cap

5.5B

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
PSMT
LQDA
Founded
1994
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Department/Specialty Retail Stores
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.2B
5.5B
IPO Year
2005
2020

Fundamental Metrics

Financial Performance
Metric
PSMT
LQDA
Price
$169.53
$33.86
Analyst Decision
Buy
Buy
Analyst Count
3
8
Target Price
★ $181.50
$54.38
AVG Volume (30 Days)
222.1K
★ 4.3M
Earning Date
10-26-2026
11-02-2026
Dividend Yield
★ 0.83%
N/A
EPS Growth
5.47
★ 51.81
EPS
★ 4.18
1.26
Revenue
★ $4,066,093,000.00
$158,320,000.00
Revenue This Year
$10.46
$357.27
Revenue Next Year
$11.62
$1.34
P/E Ratio
$40.60
★ $27.57
Revenue Growth
12.33
★ 1031.18
52 Week Low
$111.68
$21.97
52 Week High
$199.84
$93.61

Technical Indicators

Market Signals
Indicator
PSMT
LQDA
Relative Strength Index (RSI) 46.63 34.24
Support Level $166.32 $32.63
Resistance Level $177.50 $42.62
Average True Range (ATR) 3.62 2.90
MACD 0.16 0.06
Stochastic Oscillator 46.79 22.44

Price Performance

Historical Comparison
PSMT
LQDA

About PSMT PriceSmart Inc.

Pricesmart Inc is principally engaged in operating U.S.-style membership shopping warehouse clubs that offer consumer goods at low prices. The company is headquartered in San Diego, California, United States, and operates stores in the Caribbean, Costa Rica, Panama, and other regions. The company's revenue consists of net warehouse club sales from merchandise sales, membership income from annual membership fees, export sales, and other income. Its operations consist of four reportable segments; Central America, the Caribbean, Colombia, and the United States. A majority of the company's revenue is derived from Central America.

About LQDA Liquidia Corporation

Liquidia Corp is a United States-based biopharmaceutical company focused on the development, manufacturing, and commercialization of products that address unmet patient needs, with the current focus directed towards the treatment of pulmonary hypertension (PH) and pulmonary hypertension associated with interstitial lung disease. It conducts research, development, and manufacturing of novel products by applying its proprietary PRINT technology, a particle engineering platform, to enable the precise production of uniform drug particles. Its product includes YUTREPIA (treprostinil) inhalation powder, for the treatment of pulmonary arterial hypertension. The company also conducting studies on L606, an investigational, liposomal formulation of treprostinil.

Share on Social Networks: